Varicella Zoster Infection Treatment Market SWOT Analysis, Competitive Strategies And Precise Outlook

1

Varicella Zoster Infection Treatment Market
Trends 2021 Segmentation, Outlook, Industry
Report to 2027 FMI Report

• May 2021

Report Id REP-GB-6466Published On
  2018-03-21Category Healthcare,
Pharmaceuticals Medical Devices
2
AboutFuture Market Insights
Future Market Insights (FMI) is a premier
provider of syndicated research reports, custom
research reports, and consulting services. We
deliver a complete packaged solution, which
combines current market intelligence, statistical
anecdotes, technology inputs, valuable growth
insights, aerial view of the competitive
framework, and future market trends. We provide
research services at a global as well as regional
level key regions include GCC, ASEAN,
and BRIC. Our offerings cover a broad spectrum of
industries including Chemicals, Materials,
Energy, Technology, Healthcare, and Retail. We
have a global presence with delivery centers
across India specializing in providing global
research reports and country research reports.
FMI is headquartered out of London, U.K., with a
state-of-the-art delivery center located in Pune,
India. We combine our knowledge and learning from
every corner of the world to distill it to one
thing the perfect solution for our client.
Research Capabilities
Sector Coverage

• Customized Research
• Syndicated Research
• Investment Research
• Social Media Research

• Automotive and Transportation
• Electronics, Semiconductor, and ICT
• Retail and Consumer Products
• Industrial Automation and Equipment

• Chemicals Materials
• Food and Beverages
• Services and Utilities
• Energy, Mining, Oil, and Gas

Subscription Information

For detailed subscription information please
contact Hari. T (Sr. Manager - Global Business
Development) T 44 (0) 20 7692 8790 D 44
20 3287 4268 Email hari.t_at_futuremarketinsights.co
m
3
Research Methodology (1/2)

• Systematic Research Approach

In-depth secondary research is used to ascertain overall market size, top industry players, top products, industry associations, etc.
FMI formulates a detailed discussion guide to conduct expert and industry interviews
FMI develops a list of industry players (manufacturers), distributors, retailers and industry experts
FMI conducts interviews with industry experts, industry players, distributors and retailers
Data is validated by triangulation method, wherein secondary, primary and FMI analysis contribute to the final data
Data is scrutinized using MS-Excel to obtain qualitative and quantitative insights about the industry
FMI delivers industry insights and information in the required format (PDF)

• Identifying key opinion leaders
• Questionnaire design
• In-depth interviews
• Coverage across value chain

• Key industry experts
• Channel study
• Developments
• Market dynamics
• Products
• Conclusions

SOLUTION

• Market participants
• Key strengths
• Product portfolio
• Mapping as per value chain
• Key focus segments

Primary Research
Secondary Research
Paid Publications

• Linkedin
• Zoominfo
• Salesforce
• Avention

• Factiva
• GBI
• Genios
• Meltwater

• Company websites
• Company annual reports
• White papers
• Financial reports

includes sources of databases
4
Varicella Zoster Infection Treatment Market
Analysis
Future Market Insights (FMI) has published a new
report on the varicella zoster infection
treatment market titled "Varicella Zoster
Infection Treatment Market Global Industry
Analysis 2012 - 2016 and Opportunity Assessment
2017 - 2027." Varicella zoster infection
comprises two main types namely varicella
chickenpox and herpes zoster. Varicella is a
highly contagious infection with an incubation
period of 10-21 days, most commonly 14-16 days,
after which characteristic rashes appear. Acute
varicella may be complicated by secondary
bacterial skin infections, cerebellitis,
encephalitis, haemorrhagic complications, and
viral and bacterial pneumonia. The climate is a
core factor that seems to have an impact on the
epidemiology of varicella. In most of the
temperate climatic regions, 90 of the people are
infected before adolescence. In tropical
climates, VZV infection occurs later in life and
adults are more susceptible to it than
children. On the other hand, herpes zoster or
shingles is a sporadic disease that is caused by
the reactivation of latent VZV in the sensory
nerve ganglia. It is usually self-limiting and is
categorised by severe pain with dermatomal
distribution and at times followed by
post-herpetic neuralgia that can be chronic and
debilitating among the geriatric population.
Though herpes zoster can occur at any age, most
of the cases are reported after the age of 50
along with increasing risks of complications. In
order to cater to the needs of the patients and
provide a potential treatment for this infection,
companies are entering into strategic
partnerships in order to make use of the
technology of the other leading companies and are
also focussing on research and development.  
5
Varicella Zoster Infection Treatment Market
Analysis
For instance, in December 2016, Slayback and
Sandoz signed an agreement with Novartis AG for
the sale and marketing rights of Slayback Generic
Zovirax Ointment (Acyclovir Ointment). Per the
agreement Novartis obtained the sales and
marketing rights, which increased their position
in the market. Other leading companies operating
in the market are Valeant Pharmaceuticals
International Inc., Teva Pharmaceutical
Industries Ltd, Pfizer Inc., Mylan N.V., Abbott
Laboratories, GlaxoSmithKline Plc., and Dr.
Reddy's Laboratories Ltd., among
others. According to the report, the global
varicella zoster infection treatment market is
expected to register a 4.2 CAGR from 2017 to
2027. In 2016, the market was worth US 1,257.1
Mn and is expected to reach a valuation of US
1,969.1 Mn by the end of 2027. Request a Sample
Report with Table of Contents and
Figures https//www.futuremarketinsights.com/repo
rts/sample/rep-gb-6466
6
Varicella Zoster Infection Treatment Market
Analysis
Risk of Varicella in Pregnancy and the Need to
Adhere to the Guidelines of Chickenpox Treatment
to Bode Well for the Market  Primary infection
with varicella zoster in pregnancy may cause
maternal mortality or serious morbidity issues. A
particular guideline issued in 2015 assesses the
evidence regarding maternal and foetal risks of
varicella zoster virus infection in pregnancy.
The U.K. Advisory Group and Swiss and Canadian
national guidelines prescribe procedures for the
use of antiviral drugs in pregnancy. The U.K.
Advisory Group provides guidelines for chickenpox
as well. These guidelines recommend oral
acyclovir, which should be prescribed for
pregnant women within 24 hours once they present
the onset of the rash and if they have 200 weeks
of gestation or beyond. Guidelines are unanimous
nevertheless, in recommending that intravenous
acyclovir be administered in cases of severe
maternal infection. This factor along with the
fact that the rate of exposure and transmission
is extremely high in this infection and is a
threat for pregnant women and kids, is expected
to boost the growth of the varicella zoster
infection treatment market
7
Varicella Zoster Infection Treatment Market
Analysis
Preview Analysis on Global Varicella Zoster
Infection Treatment Market Segmentation By Drug
Type - Acyclovir, Valacyclovir, Famciclovir By
Route of Administration Type - Oral, Topical,
Injectable By Distribution Channel Type -
Hospital Pharmacies ,Retail Pharmacies, Online
Pharmacies, Drug Stores https//www.futuremarketi
nsights.com/reports/varicella-zoster-infection-tre
atment-market Natural Products to Challenge
Market Growth  Several people opt for other
treatment options for herpes zoster and
varicella. These alternative treatment options
are expected to hamper the growth of the
antiviral drugs market for varicella zoster
infection treatment. Homeopathy, supplements, and
other natural herbal medicines are used to treat
herpes zoster and varicella. Our advisory
services are aimed at helping you with specific,
customised insights that are relevant to your
specific challenges. Let us know about your
challenges and our trusted advisors will connect
with you https//www.futuremarketinsights.com/ask
us/rep-gb-6466
8
To know more about us, please visit our website
www.futuremarketinsights.com For sales queries
or new topics email us on sales_at_futuremarketinsi
ghts.com For media queries, contact the press
office at press_at_futuremarketinsights.com For
other queries contactHari. T (Sr. Manager -
Global Business Development) Future Market
Insights 3rd Floor,207 Regent Street, London
W1B 3HH T 44 20 7692 8790 D 44 20 3287
4268 Email hari.t_at_futuremarketinsights.com
Thank You
Future Market Insights Global Consulting
Private Limited (FMI)